|
|
Post by brentie on Jun 15, 2018 8:11:31 GMT -5
|
|
|
|
Post by centralcoastinvestor on Jun 15, 2018 8:22:54 GMT -5
Good article. It’s always good to have the company or its CEO in the news in a positive way. I love the answer to the question: What keeps you up a night? Castagna’s answer: Nothing, i feel very good about the direction of the company.
|
|
|
|
Post by mnholdem on Jun 15, 2018 8:28:36 GMT -5
Excerpt:
The company spent $2.9 billion getting Afrezza to market, and MannKind didn’t operate like a well-run pharmaceutical company, Castagna said. “We have to get the information out there. We’re already well on our way and Wall Street will catch up.” |
|
|
|
Post by golfeveryday on Jun 15, 2018 10:56:06 GMT -5
Excerpt:
The company spent $2.9 billion getting Afrezza to market, and MannKind didn’t operate like a well-run pharmaceutical company, Castagna said. “We have to get the information out there. We’re already well on our way and Wall Street will catch up.” which is $19 per share right now just to recoup that cost. |
|
